Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Gina Jamal, MD

Articles by Gina Jamal, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia

The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know

How Do Cannabis Edibles Affect Driving? New Research Insights